Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment (2022)
- Authors:
- Autor USP: BACHEGA, TÂNIA APARECIDA SARTORI SANCHEZ - FM
- Unidade: FM
- DOI: 10.3389/fendo.2022.995151
- Subjects: ANTICORPOS; GRUPOS SANGUÍNEOS; ANEMIA FALCIFORME
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in endocrinology
- ISSN: 1664-2392
- Volume/Número/Paginação/Ano: v. 13, article ID 995151, 2p, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FRAGOSO, Maria Candida Barisson Villares e BACHEGA, Tania Aparecida Sartori Sanchez e DAIN, Liliana. Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment. Frontiers in endocrinology. Lausanne: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fendo.2022.995151. Acesso em: 12 fev. 2026. , 2022 -
APA
Fragoso, M. C. B. V., Bachega, T. A. S. S., & Dain, L. (2022). Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment. Frontiers in endocrinology. Lausanne: Faculdade de Medicina, Universidade de São Paulo. doi:10.3389/fendo.2022.995151 -
NLM
Fragoso MCBV, Bachega TASS, Dain L. Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment [Internet]. Frontiers in endocrinology. 2022 ; 13[citado 2026 fev. 12 ] Available from: https://doi.org/10.3389/fendo.2022.995151 -
Vancouver
Fragoso MCBV, Bachega TASS, Dain L. Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment [Internet]. Frontiers in endocrinology. 2022 ; 13[citado 2026 fev. 12 ] Available from: https://doi.org/10.3389/fendo.2022.995151 - Effects of endocrine disruptors in the development of the female reproductive tract
- Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry
- Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure
- Os interferentes endócrinos ambientais precisam receber a atenção dos endocrinologistas brasileiros [Carta]
- High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening
- Diagnóstico da hiperplasia adrenal congênita por deficiência da 21-hidroxilase:: do fenótipo ao genótipo
- Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency
- Hiperplasia congênita das supras-renais
- Hiperplasia adrenal congênita
- The Actual Incidence of Congenital Adrenal Hyperplasia in Brazil May Not be as High as Inferred - An Estimate Based on a Public Neonatal Screening Program in the State of Goiás
Informações sobre o DOI: 10.3389/fendo.2022.995151 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
